Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome

This publication has 18 references indexed in Scilit:

• Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection
  The Journal of Pediatrics, 1992
• Nontuberculous mycobacteria in children with acquired immunodeficiency syndrome
  The Pediatric Infectious Disease Journal, 1992
• Treatment of Mycobacterium avium Complex Bacteremia in AIDS with a Four-Drug Oral Regimen
  Annals of Internal Medicine, 1992
• Disseminated Mycobacterium avium Complex Infection: Clinical Identification and Epidemiologic Trends
  The Journal of Infectious Diseases, 1992
• Survival of Patients with Acquired Immune Deficiency Syndrome and DisseminatedMycobacterium aviumComplex Infection with and without Antimycobacterial Chemotherapy
  American Review of Respiratory Disease, 1991
• Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages
  Antimicrobial Agents and Chemotherapy, 1991
• Treatment of Disseminated Mycobacterium avium Complex Infection in AIDS with Amikacin, Ethambutol, Rifampin, and Ciprofloxacin
  Annals of Internal Medicine, 1990
• Quadruple-Drug Therapy for Mycobacterium avium-intracellulare Bacteremia in AIDS Patients
  The Journal of Infectious Diseases, 1990
• In vitro and in vivo activities of clarithromycin against Mycobacterium avium
  Antimicrobial Agents and Chemotherapy, 1989
• Mycobacterium avium-intracellulare: A Cause of Disseminated Life-Threatening Infection in Homosexuals and Drug Abusers
  Annals of Internal Medicine, 1982